Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-066962
Filing Date
2025-05-08
Accepted
2025-05-08 16:11:48
Documents
75
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q orgo-20250331.htm   iXBRL 10-Q 1735558
2 EX-10.1 orgo-ex10_1.htm EX-10.1 37293
3 EX-31.1 orgo-ex31_1.htm EX-31.1 16540
4 EX-31.2 orgo-ex31_2.htm EX-31.2 17092
5 EX-32.1 orgo-ex32_1.htm EX-32.1 17615
  Complete submission text file 0000950170-25-066962.txt   7619451

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT orgo-20250331.xsd EX-101.SCH 1100659
78 EXTRACTED XBRL INSTANCE DOCUMENT orgo-20250331_htm.xml XML 1254253
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37906 | Film No.: 25926208
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)